Pooled Safety Analysis Of Adjudicated Serious Adverse Events With The Fixed-Dose Combination Of Tiotropium plus Olodaterol

被引：0
|
作者：
Buhl, R. [1 ]
Tetzlaff, K. [2 ]
Korducki, L. [3 ]
Vogelmeier, C. [4 ]
McGarvey, L. [5 ]
机构：
[1] Mainz Univ Hosp, Pulm Dept, Mainz, Germany
[2] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[3] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
[4] Univ Marburg, Dept Resp Dis, Marburg, Germany
[5] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5756
引用
收藏
页数：2
相关论文
共 50 条
  • [1] POOLED SAFETY ANALYSIS OF ADJUDICATED SERIOUS ADVERSE EVENTS WITH THE COMBINATION OF TIOTROPIUM plus OLODATEROL
    Buhl, R.
    Tetzlaff, K.
    Korducki, L.
    Vogelmeier, C.
    McGarvey, L.
    [J]. THORAX, 2015, 70 : A140 - A140
  • [2] Safety of tiotropium and olodaterol fixed-dose combination for COPD in patients on β-blockers
    McGarvey, Lorcan
    Buhl, Roland
    Korducki, Lawrence
    Amatto, Valeria C.
    Tetzlaff, Kay
    Bjermer, Leif
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [3] Analysis Of The Efficacy And Safety Of The Fixed-Dose Combination Of Tiotropium plus Olodaterol In Patients With COPD By Initial Disease Severity
    Korn, S.
    Buhl, R.
    Gronke, L.
    Korducki, L.
    Amatto, V. C.
    Ferguson, G. T.
    Abrahams, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [4] Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination
    Rogliani, Paola
    Ritondo, Beatrice Ludovica
    Zerillo, Bartolomeo
    Cazzola, Mario
    Matera, Maria Gabriella
    Calzetta, Luigino
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 17 (02) : 215 - 223
  • [5] Analysis Of The Efficacy And Safety Of The Fixed-Dose Combination Of Tiotropium plus Olodaterol In Patients With COPD By Previous Usage Of Inhaled Corticosteroids
    Korn, S.
    Buhl, R.
    Gronke, L.
    Korducki, L.
    Amatto, V. C.
    Ferguson, G. T.
    Abrahams, R.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [6] THE FIXED-DOSE COMBINATION OF TIOTROPIUM plus OLODATEROL HAS A RAPID ONSET OF ACTION IN PATIENTS WITH COPD
    Veale, A.
    Ferguson, G.
    Pizzichini, E.
    Flezar, M.
    Groenke, L.
    Korducki, L.
    [J]. RESPIROLOGY, 2016, 21 : 129 - 129
  • [7] The fixed-dose combination of tiotropium plus olodaterol has a rapid onset of action in patients with COPD
    Ferguson, Gary T.
    Pizzichini, Emilio
    Flezar, Matjaz
    Groenke, Lars
    Korducki, Lawrence
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [8] Pharmacokinetics and safety of tiotropium plus olodaterol 5 μg/5 μg fixed-dose combination in Chinese patients with COPD
    Wang, Zhenlei
    Tadayasu, Yusuke
    Hu, Na
    Shu, Shiqing
    Hu, Chao
    Luo, Zhu
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2020, 63
  • [9] Efficacy of tiotropium and olodaterol fixed-dose combination in patients with COPD on β-blockers
    Derom, Eric
    Korn, Stephanie
    Hamilton, Alan
    Amatto, Valeria C.
    Zhao, Yihua
    Maltais, Francois
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [10] Cost-effectiveness of the fixed-dose combination tiotropium plus olodaterol based on the DYNAGITO trial results
    Hoogendoorn, Martine
    Ramos, Isaac Corro
    Baldwin, Michael
    Luciani, Laura
    Fabron, Cecile
    Detournay, Bruno
    Rutten-Van Molken, Maureen
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
12345